This inventor holds 1 USPTO granted patent. Top assignee: Medeva Europe Limited. Active years: 2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2000
Title: Hesta Varey McNeill: Innovator in Vaccine Development
Introduction
Hesta Varey McNeill is a prominent inventor based in Newcastle upon Tyne, GB. She has made significant contributions to the field of vaccine development, particularly through her innovative approaches to creating safe and effective vaccines.
Latest Patents
Hesta holds a patent for "Non antibiotic selectable markers for live vaccines." This invention relates to DNA constructs that encode a safe, selectable marker, which is not an antibiotic resistance marker. The constructs are designed for use in vectors and cells, leading to the development of vaccines that can be utilized in both animals and humans. The safe, selectable marker confers resistance to an agent that would otherwise negatively impact the growth of the cell containing the construct.
Career Highlights
Hesta is currently employed at Medeva Europe Limited, where she continues to advance her research and development efforts in the field of vaccines. Her work is crucial in addressing the challenges associated with antibiotic resistance in vaccine development.
Collaborations
Hesta collaborates with notable colleagues, including Mohammed Anjam Khan and Carlos Estenio Hormaeche. Their combined expertise contributes to the innovative projects at Medeva Europe Limited.
Conclusion
Hesta Varey McNeill is a trailblazer in the field of vaccine innovation, with her patent highlighting the importance of developing safe alternatives to antibiotic resistance markers. Her work continues to impact the future of vaccine development positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile